CCR10
Basic information
Region (hg38): 17:42678889-42683917
Previous symbols: [ "GPR2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CCR10 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 18 | 20 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 18 | 1 | 2 |
Variants in CCR10
This is a list of pathogenic ClinVar variants found in the CCR10 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-42679593-G-A | not specified | Uncertain significance (May 27, 2022) | ||
17-42679645-C-T | not specified | Uncertain significance (Oct 17, 2023) | ||
17-42679657-T-C | not specified | Likely benign (Jan 04, 2022) | ||
17-42679665-C-T | not specified | Uncertain significance (Mar 02, 2023) | ||
17-42679707-A-T | not specified | Uncertain significance (Aug 07, 2024) | ||
17-42679710-G-C | not specified | Uncertain significance (Sep 27, 2021) | ||
17-42679791-G-T | not specified | Uncertain significance (Nov 21, 2022) | ||
17-42679843-G-T | not specified | Uncertain significance (Aug 19, 2024) | ||
17-42679893-A-G | not specified | Uncertain significance (Jul 02, 2024) | ||
17-42680152-T-C | not specified | Uncertain significance (Nov 15, 2021) | ||
17-42680177-G-C | Benign (Dec 31, 2019) | |||
17-42680197-C-A | not specified | Uncertain significance (Feb 23, 2023) | ||
17-42680215-C-T | not specified | Uncertain significance (Nov 30, 2022) | ||
17-42680224-C-A | not specified | Uncertain significance (Nov 17, 2022) | ||
17-42680307-G-A | not specified | Uncertain significance (Feb 28, 2024) | ||
17-42680401-G-C | not specified | Uncertain significance (Apr 09, 2024) | ||
17-42680409-G-A | not specified | Uncertain significance (Sep 20, 2023) | ||
17-42680466-T-C | not specified | Uncertain significance (Sep 22, 2022) | ||
17-42680491-C-T | not specified | Uncertain significance (Jul 11, 2023) | ||
17-42680497-G-C | not specified | Uncertain significance (Nov 10, 2022) | ||
17-42680559-G-C | not specified | Uncertain significance (May 17, 2023) | ||
17-42680565-G-A | not specified | Uncertain significance (Dec 08, 2023) | ||
17-42680574-G-A | not specified | Uncertain significance (Oct 25, 2022) | ||
17-42681816-G-A | Benign (Feb 08, 2018) | |||
17-42682613-G-C | Benign (Sep 04, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CCR10 | protein_coding | protein_coding | ENST00000332438 | 2 | 5029 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000505 | 0.701 | 125593 | 0 | 12 | 125605 | 0.0000478 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.89 | 130 | 206 | 0.630 | 0.0000111 | 2192 |
Missense in Polyphen | 48 | 79.869 | 0.60098 | 949 | ||
Synonymous | 2.82 | 69 | 106 | 0.651 | 0.00000580 | 889 |
Loss of Function | 0.838 | 6 | 8.66 | 0.693 | 4.70e-7 | 79 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000606 | 0.0000606 |
Ashkenazi Jewish | 0.000114 | 0.0000994 |
East Asian | 0.0000645 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000203 | 0.0000176 |
Middle Eastern | 0.0000645 | 0.0000544 |
South Asian | 0.000199 | 0.000196 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for chemokines SCYA27 and SCYA28. Subsequently transduces a signal by increasing the intracellular calcium ions level and stimulates chemotaxis in a pre-B cell line.;
- Pathway
- Chemokine signaling pathway - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human);Intestinal immune network for IgA production - Homo sapiens (human);Peptide GPCRs;Chemokine signaling pathway;GPCRs, Class A Rhodopsin-like;Signaling by GPCR;Signal Transduction;Chemokine receptors bind chemokines;Peptide ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (i) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.119
Intolerance Scores
- loftool
- 0.481
- rvis_EVS
- 0.3
- rvis_percentile_EVS
- 72.01
Haploinsufficiency Scores
- pHI
- 0.224
- hipred
- N
- hipred_score
- 0.375
- ghis
- 0.501
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.898
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ccr10
- Phenotype
- muscle phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- chemotaxis;immune response;G protein-coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;calcium-mediated signaling;cell chemotaxis;chemokine-mediated signaling pathway
- Cellular component
- endoplasmic reticulum;plasma membrane;integral component of plasma membrane;external side of plasma membrane;cell surface
- Molecular function
- G protein-coupled receptor activity;protein binding;C-C chemokine receptor activity;chemokine binding;C-C chemokine binding